<DOC>
	<DOCNO>NCT02784964</DOCNO>
	<brief_summary>1 . To assess safety allogeneic injection expand ADSCs patient knee osteoarthritis 2 . To assess efficacy allogeneic injection expand ADSCs patient knee osteoarthritis</brief_summary>
	<brief_title>Adipose-derived Stem Cells ( ADSCs ) Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Aged 4080 year ( inclusive ) 2 . KellgrenLawrence grade IIII , determine American College Rheumatology ( ACR ) criteria osteoarthritis knee 3 . Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) pain score 717 study knee even treat chronic dos non steroidal antiinflammatory drug 4 . Having provide informed consent 1 . With previous surgery articular fracture , ligament reconstruction , meniscal reconstruction , knee arthroplasty target knee joint 2 . With previous intraarticular intervention target knee joint within past 3 month ( e.g . steroid , anaesthetic , sodium hyaluronate ) 3 . Known suspected infection target knee joint 4 . Ascertained hypersensitivity component use study 5 . Administered systemic antiinflammatory drug ( e.g . nonsteroidal antiinflammatory drug steroid ) topical antiinflammatory drug target knee within 7 day prior administration study 6 . With serious prior ongoing medical condition ( e.g . concomitant illness cardiovascular ( e.g . New York Heart Association grade III IV ) , hepatic ( e.g . ChildPugh Class C ) , psychiatric condition , alcoholism , drug abuse ) , medical history , physical finding , , laboratory abnormality investigator ' opinion could interfere result trial adversely affect safety patient 7 . With evidence malignant disease life expectancy le 1 year 8 . Pregnant lactate woman plan pregnant study period 9 . With body mass index ( BMI ) great equal 35 kg/m2 10 . With joint disease except knee osteoarthritis consider investigator eligible enter study 11 . With known history human immunodeficiency virus ( HIV ) infection . 12 . Judged applicable study investigator difficulty followup observation 13 . With serious diseases/medical history consider investigator condition enter trial 14 . Having participate investigational study within 4 week enter study 15 . With known history claustrophobia 16 . Having exist active/inactive implant medical device , cardiac pacemaker , cochlear , intracranial vascular clip neurostimulator , etc ... 17 . Having exist metallic intraocular foreign body</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>